Resverlogix (RVX) Insider Trading & Ownership C$0.05 +0.01 (+11.11%) As of 02/14/2025 03:36 PM Eastern Add Compare Share Share Insider Trades Stock AnalysisChartCompetitorsEarningsHeadlinesInsider Trades Resverlogix (TSE:RVX) Insider Buying and Selling ActivityCurrentInsider OwnershipPercentage42.66%Number OfInsiders Buying(Last 12 Months)0Number OfInsiders Selling(Last 12 Months)1Amount OfInsider Selling(Last 12 Months)C$1,500.00 Get RVX Insider Trade Alerts Want to know when executives and insiders are buying or selling Resverlogix stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address RVX Insider Buying and Selling by Quarter Resverlogix Insider and Congressional Trades History Insiders and Members of Congress Insiders Only Members of Congress Only Transaction Type Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years Time Frame Start Date End Date Export to Excel Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails11/22/2024Aaron Bradley CannSenior OfficerSell25,000C$0.06C$1,500.00 (Data available from 1/1/2013 forward) RVX Insider Trading Activity - Frequently Asked Questions Who is on Resverlogix's Insider Roster? The list of insiders at Resverlogix includes Aaron Bradley Cann, and Donald J. Mccaffrey. Learn more on insiders at RVX. What percentage of Resverlogix stock is owned by insiders? 42.66% of Resverlogix stock is owned by insiders. Learn more on RVX's insider holdings. Which Resverlogix insiders have been selling company stock? The following insider sold RVX shares in the last 24 months: Aaron Bradley Cann (C$1,500.00). How much insider selling is happening at Resverlogix? Insiders have sold a total of 25,000 Resverlogix shares in the last 24 months for a total of C$1,500.00 sold. Resverlogix Key ExecutivesMr. Donald J. McCaffreyCo-Founder, Chairman, President, CEO & SecretaryMr. Aaron Bradley Cann C.A.CPA, CBV, Chief Financial Officer1 recent tradesDr. Ewelina Kulikowski Ph.D.Chief Scientific OfficerDr. Michael Sweeney M.D. (Age 63)Senior Vice President of Clinical Development Compensation: $511.56kSarah ZapotichnyDirector of Investor Relations & Corporate Communications More Insider Trading Tools from MarketBeat Related Companies Hemostemix Insider Buying Antibe Therapeutics Insider Buying Kane Biotech Insider Buying Innovotech Insider Buying Quest PharmaTech Insider Buying Fennec Pharmaceuticals Insider Buying Insider Tracking Tools CEO Purchases/Sales CFO Purchases/Sales Top Insider Buying Stocks Top Insider Selling Stocks Insider Trades Screener Insider Trades Newsletter Congressional Stock Trades Insider Trading By Country U.S. Insider Trading Activity Canadian Insider Trading Activity U.K. Insider Trading Activity Australia Insider Trading Activity Latest Articles META Stock: Insider Selling Ramps Up—What It Means for InvestorsThese Are the Dividend Stocks Insiders Bought in JanuaryInsider Selling in Tech Stocks Spikes in Q43 Small-Cap Stocks Insiders and Institutions Are Buying3 Stocks With Strong Capital Returns and Insider Buying Signals This page (TSE:RVX) was last updated on 2/17/2025 by MarketBeat.com Staff From Our PartnersCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredElon “obliterates” Bill Gates?All 10 of the world's biggest money managers follow my work, and the Pentagon, the FBI and Harvard professors ...Altimetry | SponsoredNVDA Crash UpdateAn overseas AI rival sent shockwaves through the U.S. tech market last week... Leaving millions of investor...Chaikin Analytics | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | Sponsored Is Starlink Set For The Largest IPO In History?He turned PayPal from a tiny, off-the-radar startup… to a massive $64 billion giant. Then, he did it again ...Paradigm Press | SponsoredHas Trump finally met his match?Dylan Jovine predicted the 2008 crash over a year before it happened. Folks who listened to him had the chance...Behind the Markets | SponsoredBuy this AI Stock Before Elon’s AnnouncementWith Trump back in office, xAI is primed to become the leader in generative AI, leaving competitors in the dus...InvestorPlace | SponsoredTop Picks for Trump’s Pro-Crypto America10,000% Crypto Opportunities in 2025 27 of the brightest minds in crypto share exclusive intel… Crypto 101 Media | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Resverlogix Corp. Please log in to your account or sign up in order to add this asset to your watchlist. Share Resverlogix With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.